1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Rat |
Synonyms | PRR4,LNIR,Nectin cell adhesion molecule 4,PVRL4,Ig superfamily receptor LNIR,Poliovirus receptor-related protein 4,NECTIN4,Poliovirus Receptor-Related 4,Nectin-4,Nectin 4,EDSS1 |
Accession | D3ZET1 |
Amino Acid Sequence | Tyr28-Val348, with C-terminal His |
Expression System | HEK293 |
Molecular Weight | 40-42kDa (Reducing) |
Purity | >95% by SDS-PAGE |
Endotoxin | <0.1EU/μg |
Conjugation | Unconjugated |
Tag | His Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | PBS, pH7.4. |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage |
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Reference | 1. Reymond, N. et al. (2001) J. Biol. Chem. 276:43205. 2.Takai, Y. et al. (2008) Nat. Rev. Mol. Cell Biol. 9:603. 3.Fabre, S. et al. (2002) J. Biol. Chem. 277:27006. |
Background
Nectin-4 (gene name PVRL4, poliovirus receptor-like 4) is a 66 kDa type I transmembrane glycoprotein belonging to the Nectin family of Ig superfamily proteins. Nectin extracellular domains (ECDs) contain three Ig-like domains: an N-terminal V-type that mediates ligand binding, and two C2-type .Human Nectin-4 is normally expressed in the placenta, especially in endothelial cells, while in the mouse it is found in the embryo, lung, testis and brain. In humans, mutation of Nectin-4 has been correlated with ectodermal dysplasia-syndactyly syndrome,High Nectin-4/PVRL4 expression was associated with poor-prognosis in some invasive breast cancers and may be a new promising prognostic biomarker and specific therapeutic target.
Picture
Picture
SDS-PAGE
ELISA

Immobilized Nectin-4 His Tag Protein, Rat (Cat. No. UA010687) at 2.0μg/mL (100μL/well) can bind Anti-Human Nectin-4 (Enfortumab) with EC50 of 1.17-2.09ng/mL.
